Company Filing History:
Years Active: 2017
Title: **Innovative Contributions of Darrell Swicegood in Radioisotope Production**
Introduction
Darrell Swicegood, an inventive mind based in Maryville, TN, has made significant contributions to the field of radiopharmaceuticals. With one patent to his name, he has developed a noteworthy invention that enhances the production of radioisotopes, which are critical for medical applications.
Latest Patents
Swicegood's patent, titled "Radioisotope Target Assembly," describes an advanced target assembly designed to produce radioisotopes for the synthesis of radiopharmaceuticals. This innovative target assembly comprises a target vessel with a target chamber that receives a target material. A thin cover sheet composed of particle-permeable material protects the target chamber. During the bombardment process, a high-energy particle beam generated by a cyclotron or particle accelerator strikes this cover sheet, allowing particles from the beam to penetrate and interact with the target material. This interaction alters the nuclear makeup of some atoms within the target material, thereby producing crucial radioisotopes.
Career Highlights
Darrell Swicegood is associated with Abt Molecular Imaging, Inc., where he has been instrumental in advancing technologies in molecular imaging. His innovative work in the development of the radioisotope target assembly highlights his commitment to improving the production processes for essential medical isotopes. His expertise in this niche area positions him as a valuable contributor to the field of radiopharmaceuticals.
Collaborations
Throughout his career, Swicegood has collaborated with other esteemed professionals, including Ronald Nutt and David Patton, Sr. These partnerships have fostered an environment of innovation within Abt Molecular Imaging, further enhancing the development of advanced imaging solutions and radioisotope production technologies.
Conclusion
In summary, Darrell Swicegood's work in developing the radioisotope target assembly demonstrates the impact of his innovations on the field of medical imaging and radiopharmaceuticals. With continual advancements in technology, his contributions could lead to improved outcomes in medical applications reliant on radioisotopes, showcasing the importance of innovation in healthcare.